Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

DNLI

Denali Therapeutics (DNLI)

Denali Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DNLI
DateTimeSourceHeadlineSymbolCompany
05/08/20233:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNLIDenali Therapeutics Inc
05/08/20233:01PMGlobeNewswire Inc.Denali Therapeutics Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:DNLIDenali Therapeutics Inc
04/20/20234:09PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:DNLIDenali Therapeutics Inc
04/18/20233:08PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DNLIDenali Therapeutics Inc
04/18/20233:05PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DNLIDenali Therapeutics Inc
04/18/20233:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DNLIDenali Therapeutics Inc
04/14/20235:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
04/12/20237:00AMGlobeNewswire Inc.Biogen Exercises Option with Denali to Develop and Commercialize Antibody Transport Vehicle Program Targeting Amyloid BetaNASDAQ:DNLIDenali Therapeutics Inc
04/10/20237:00AMGlobeNewswire Inc.Denali Therapeutics Announces New DNL343 (eIF2B Agonist) Phase 1b Data in ALS To Be Presented at the Upcoming AAN Annual MeetingNASDAQ:DNLIDenali Therapeutics Inc
02/27/20233:08PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:DNLIDenali Therapeutics Inc
02/27/20233:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNLIDenali Therapeutics Inc
02/27/20233:01PMGlobeNewswire Inc.Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:DNLIDenali Therapeutics Inc
02/22/20233:33PMGlobeNewswire Inc.Denali Therapeutics Announces New Interim Data from DNL310 Phase 1/2 Study for MPS II and DNL126 Preclinical Data for MPS IIIA at WORLDSymposium™NASDAQ:DNLIDenali Therapeutics Inc
02/15/20233:01PMGlobeNewswire Inc.Denali Therapeutics Announces Presentations on Enzyme Transport Vehicle (ETV) Development Programs for MPS Diseases at the Upcoming WORLDSymposium™NASDAQ:DNLIDenali Therapeutics Inc
02/13/20233:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNLIDenali Therapeutics Inc
02/10/20235:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
02/10/20235:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
02/10/20235:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
02/09/20237:16AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNLIDenali Therapeutics Inc
01/25/20237:00AMGlobeNewswire Inc.Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by SanofiNASDAQ:DNLIDenali Therapeutics Inc
01/20/20239:06AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNLIDenali Therapeutics Inc
01/19/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
01/09/20233:06PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:DNLIDenali Therapeutics Inc
01/09/20237:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNLIDenali Therapeutics Inc
01/09/20237:00AMGlobeNewswire Inc.Denali Therapeutics Announces Key Anticipated 2023 Milestones for Its Therapeutic Portfolio for Neurodegeneration and Lysosomal Storage DiseasesNASDAQ:DNLIDenali Therapeutics Inc
12/05/20224:25PMTipRanksDenali Therapeutics (DNLI) Gets a Buy from Berenberg BankNASDAQ:DNLIDenali Therapeutics Inc
12/05/20226:00AMGlobeNewswire Inc.Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform TrialNASDAQ:DNLIDenali Therapeutics Inc
11/20/20227:55PMTipRanksDenali Therapeutics (DNLI) Receives a New Rating from Berenberg BankNASDAQ:DNLIDenali Therapeutics Inc
11/08/202210:35AMTipRanksMorgan Stanley Keeps Their Buy Rating on Denali Therapeutics (DNLI)NASDAQ:DNLIDenali Therapeutics Inc
11/08/20225:10AMTipRanksAnalysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC), Denali Therapeutics (DNLI) and BioNTech SE (BNTX)NASDAQ:DNLIDenali Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DNLI

Your Recent History

Delayed Upgrade Clock